Establishment and characterization of UTI and CAUTI in a mouse model

Journal of Visualized Experiments

Volumn 2015, Issue 100, 2015, Pages

  Conover, Matt S ^a   Flores Mireles, Ana L ^a   Hibbing, Michael E ^a   Dodson, Karen ^a   Hultgren, Scott J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Catheter; Chronic cystitis; Enterococcus faecalis; Escherichia coli; IBC; Issue 100; Medicine; UPEC; Urinary tract infection; Uropathogenic

Indexed keywords

ANIMAL; C3H MOUSE; C57BL MOUSE; CATHETER INFECTION; DISEASE MODEL; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI INFECTIONS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; MICROBIOLOGY; MOUSE; PATHOGENICITY; URINARY CATHETER; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI;

ANIMALS; CATHETER-RELATED INFECTIONS; DISEASE MODELS, ANIMAL; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI INFECTIONS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; URINARY CATHETERS; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84941247993     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/52892     Document Type: Article

References (70)

1. Foxman, B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 49, 53-70, doi:10.1067/ mda.2003.7S0011502903000038 [pii] (2003).
2. Foxman, B. et al. Risk factors for second urinary tract infection among college women. American journal of epidemiology. 151, 1194-1205 (2000).
3. Gupta, K., Hooton, T. M., & Stamm, W. E. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Annals of internal medicine. 135, 41-50, doi:10.7326/0003-4819-135-1-200107030-00012 (2001).
4. Gupta, K., Hooton, T. M., & Stamm, W. E. Isolation of fluoroquinolone-resistant rectal Escherichia coli. after treatment of acute uncomplicated cystitis. The Journal of antimicrobial chemotherapy. 56, 243-246, doi: 10.1093/jac/dki169 (2005).
5. Gupta, K., Sahm, D. F., Mayfield, D., & Stamm, W. E. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 33, 89-94, doi:CID000971 [pii]10.1086/320880 (2001).
6. Gupta, K., Scholes, D., & Stamm, W. E. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. Jama. 281, 736-738, doi:10.1001/jama.281.8.736 (1999).
7. Jarvis, W. R. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol. 17, 552-557 (1996).
8. Lo, E. et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America. 35, 464-479, doi:10.1086/675718 (2014).
9. Foxman, B. The epidemiology of urinary tract infection. Nature reviews Urology. 7, 653-660 doi: 10.1038/nrurol.2010.190 (2010).
10. Hooton, T. M., & Stamm, W. E. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 11, 551-581, doi: 10.1016/S0891-5520(05)70373-1 (1997).
11. Hannan, T. J. et al. LeuX tRNA-dependent and -independent mechanisms of Escherichia coli. pathogenesis in acute cystitis. Molecular microbiology. 67, 116-128, doi:MMI6025 [pii]10.1111/j.1365-2958.2007.06025.x (2008).
12. Cusumano, C. K., Hung, C. S., Chen, S. L., & Hultgren, S. J. Virulence plasmid harbored by uropathogenic Escherichia coli. functions in acute stages of pathogenesis. Infection and immunity. 78, 1457-1467, doi:10.1128/IAI.01260-09 (2010).
13. Dhakal, B. K., & Mulvey, M. A. The UPEC pore-forming toxin alpha-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways. Cell host & microbe. 11, 58-69, doi:10.1016/j.chom.2011.12.003 (2012).
14. Garcia, E. C., Brumbaugh, A. R., & Mobley, H. L. Redundancy and specificity of Escherichia coli. iron acquisition systems during urinary tract infection. Infection and immunity. 79, 1225-1235, doi:10.1128/IAI.01222-10 (2011).
15. Bergsten, G., Wullt, B., & Svanborg, C. Escherichia coli., fimbriae, bacterial persistence and host response induction in the human urinary tract. International journal of medical microbiology: IJMM. 295, 487-502, doi:10.1016/j.ijmm.2005.07.008 (2005).
16. Zhou, G. et al. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli.: evidence from in vitro FimH binding. J Cell Sci. 114, 4095-4103 (2001).
17. Eto, D. S., Jones, T. A., Sundsbak, J. L., & Mulvey, M. A. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli.. PLoS Pathog. 3, e100, doi:07-PLPA-RA-0045 [pii]10.1371/journal.ppat.0030100 (2007).
18. Taganna, J., de Boer, A. R., Wuhrer, M., & Bouckaert, J. Glycosylation changes as important factors for the susceptibility to urinary tract infection. Biochemical Society transactions. 39, 349-354, doi:10.1042/BST0390349 (2011).
19. Mulvey, M. A. et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.. Science. 282, 1494-1497, doi: 10.1126/science.282.5393.1494 (1998).
20. Mysorekar, I. U., Mulvey, M. A., Hultgren, S. J., & Gordon, J. I. Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli.. The Journal of biological chemistry. 277, 7412-7419, doi: 10.1074/jbc.M110560200 (2002).
21. Schwartz, D. J., Chen, S. L., Hultgren, S. J., & Seed, P. C. Population Dynamics and Niche Distribution of Uropathogenic Escherichia coli. during Acute and Chronic Urinary Tract Infection. Infect. Immun. 79, 4250-4259, doi:10.1128/iai.05339-11 (2011).
22. Garofalo, C. K. et al. Escherichia coli. from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation. Infection and immunity. 75, 52-60, doi:10.1128/IAI.01123-06 (2007).
23. Justice, S. S. et al. Differentiation and developmental pathways of uropathogenic Escherichia coli. in urinary tract pathogenesis. Proc Natl Acad Sci USA. 101, 1333-1338, doi:10.1073/pnas.0308125100 (2004).
24. Rosen, D. A. et al. Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae. urinary tract infection and the effects of FimK on type 1 pilus expression. Infection and immunity. 76, 3337-3345 doi: 10.1128/IAI.00090-08 (2008).
25. Anderson, G. G. et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science. 301, 105-107, doi: 10.1126/science.1084550 (2003).
26. Robino, L. et al. Detection of intracellular bacterial communities in a child with Escherichia coli. recurrent urinary tract infections. Pathogens and disease. 68, 78-81, doi:10.1111/2049-632X.12047 (2013).
27. Rosen, D. A., Hooton, T. M., Stamm, W. E., Humphrey, P. A., & Hultgren, S. J. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med. 4, e329, doi:10.1371/journal.pmed.0040329 (2007).
28. Horsley, H. et al.Enterococcus faecalis. subverts and invades the host urothelium in patients with chronic urinary tract infection. PloS one. 8, e83637, doi:10.1371/journal.pone.0083637 (2013).
29. Hopkins, W. J., Uehling, D. T., & Wargowski, D. S. Evaluation of a familial predisposition to recurrent urinary tract infections in women. American Journal of Medical Genetics. 83, 422-424, doi: 10.1002/(SICI)1096-8628(19990423)83:5<422::AID-AJMG16>3.0.CO;2-1 (1999).
30. Hopkins, W. J., Gendron-Fitzpatrick, A., Balish, E., & Uehling, D. T. Time course and host responses to Escherichia coli. urinary tract infection in genetically distinct mouse strains. Infection and immunity. 66, 2798-2802 (1998).
31. Mabeck, C. E. Treatment of uncomplicated urinary tract infection in non-pregnant women. Postgraduate medical journal. 48, 69-75, doi:10.1136/pgmj.48.556.69 (1972).
32. Ferry, S., Holm, S., Stenlund, H., Lundholm, R., & Monsen, T. The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study. Scandinavian Journal of Infectious Diseases. 36, 296-301, doi:10.1080/00365540410019642 (2004).
33. Hannan, T. J., Mysorekar, I. U., Hung, C. S., Isaacson-Schmid, M. L., & Hultgren, S. J. Early severe inflammatory responses to uropathogenic E. coli. predispose to chronic and recurrent urinary tract infection. PLoS Pathog. 6, doi:10.1371/journal.ppat.1001042 (2010).
34. Mysorekar, I. U., & Hultgren, S. J. Mechanisms of uropathogenic Escherichia coli. persistence and eradication from the urinary tract. Proc Natl Acad Sci USA. 103, 14170-14175, doi:10.1073/pnas.0602136103 (2006).
35. Glahn, B. E., Braendstrup, O., & Olesen, H. P. Influence of drainage conditions on mucosal bladder damage by indwelling catheters. II. Histological study. Scandinavian journal of urology and nephrology. 22, 93-99 (1988).
36. Goble, N. M., Clarke, T., & Hammonds, J. C. Histological changes in the urinary bladder secondary to urethral catheterisation. British journal of urology. 63, 354-357, doi: 10.1111/j.1464-410X.1989.tb05216.x (1989).
37. Ronald, A. The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon. 49, 71-82, doi:10.1016/ S0002-9343(02)01055-0 (2003).
38. Arias, C. A., & Murray, B. E. The rise of the Enterococcus.: beyond vancomycin resistance. Nature reviews. Microbiology. 10, 266-278, doi:10.1038/nrmicro2761 (2012).
39. Garibaldi, R. A., Burke, J. P., Dickman, M. L., & Smith, C. B. Factors predisposing to bacteriuria during indwelling urethral catheterization. The New England journal of medicine. 291, 215-219, doi:10.1056/NEJM197408012910501 (1974).
40. Warren, J. W. Catheter-associated urinary tract infections. Infect Dis Clin North Am. 11, 609-622, doi: doi:10.1016/S0891-5520(05)70376-7 (1997).
41. Guiton, P. S., Hung, C. S., Hancock, L., Caparon, M. G., & Hultgren, S. J. Enterococcal. biofilm formation and virulence in an optimized murine model of foreign body-associated urinary tract infections. Infection and immunity. 78, 4166-4175 doi: 10.1128/IAI.00711-10 (2010).
42. Flores-Mireles, A. L., Pinkner, J. S., Caparon, M. G., & Hultgren, S. J. EbpA vaccine antibodies block binding of Enterococcus faecalis. to fibrinogen to prevent catheter-associated bladder infection in mice. Science translational medicine. 6, 254ra127, doi:10.1126/ scitranslmed.3009384 (2014).
43. Martinez, J. J., Mulvey, M. A., Schilling, J. D., Pinkner, J. S., & Hultgren, S. J. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. The EMBO Journal. 19, 2803-2812 (2000).
44. Hultgren, S. J., Schwan, W. R., Schaeffer, A. J., & Duncan, J. L. Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli.. Infection and immunity. 54, 613-620 (1986).
45. Chenoweth, C. E., Gould, C. V., & Saint, S. Diagnosis, Management, and Prevention of Catheter-Associated Urinary Tract Infections. Infect. Dis. Clin. North Am. 28, 105-+, doi:10.1016/j.idc.2013.09.002 (2014).
46. Foxman, B. The epidemiology of urinary tract infection. Nature Reviews Urology. 7, 653-660, doi:10.1038/nrurol.2010.190 (2002).
47. Justice, S. S., Hunstad, D. A., Seed, P. C., & Hultgren, S. J. Filamentation by Escherichia coli. subverts innate defenses during urinary tract infection. Proc Natl Acad Sci USA. 103, 19884-19889, doi:10.1073/pnas.0606329104 (2006).
48. Song, J. et al. TLR4-mediated expulsion of bacteria from infected bladder epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 106, 14966-14971 doi: 10.1073/pnas.0900527106 (2009).
49. Wang, H., Min, G., Glockshuber, R., Sun, T., & Kong, X. P. Uropathogenic E. coli. adhesin-induced host cell receptor conformational changes: implications in transmembrane signaling transduction. Journal of molecular biology. 392, 352-361 doi: 10.1016/j.jmb.2009.06.077 (2009).
50. Cusumano, C. K. et al. Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Science translational medicine. 3, 109-115 doi: 10.1126/scitranslmed.3003021 (2011).
51. Langermann, S., & Ballou, W. R., Jr.. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli. urinary tract infections. J Infect Dis. 183, S84-86, doi: 10.1086/318857 (2001).
52. Langermann, S. et al. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.. J Infect Dis. 181, 774-778, doi:JID990811 [pii]10.1086/315258 (2000).
53. Langermann, S. et al. Prevention of mucosal Escherichia coli. infection by FimH-adhesin-based systemic vaccination. Science. 276, 607-611, doi: 10.1126/science.276.5312.607 (1997).
54. Alteri, C. J., Hagan, E. C., Sivick, K. E., Smith, S. N., & Mobley, H. L. T. Mucosal Immunization with Iron Receptor Antigens Protects against Urinary Tract Infection. Plos Pathogens. 5, doi:e100058610.1371/journal.ppat.1000586 (2009).
55. Russo, T. A. et al. The siderophore receptor IroN of extraintestinal pathogenic Escherichia coli. is a potential vaccine candidate. Infect. Immun. 71, 7164-7169, doi:10.1128/iai.71.12.7164-7169.2003 (2003).
56. Schwartz, D. J. et al. Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation. Proceedings of the National Academy of Sciences of the United States of America. 110, 15530-15537, doi:10.1073/pnas.1315203110 (2013).
57. Czaja, C. A. et al. Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli. recurrent urinary tract infection in women. J Infect Dis. 200, 528-536, doi:10.1086/600385 (2009).
58. Chen, S. L. et al. Genomic Diversity and Fitness of E. coli. Strains Recovered from the Intestinal and Urinary Tracts of Women with Recurrent Urinary Tract Infection. Science Translational Medicine. 5. doi: 10.1126/scitranslmed.3005497 (2013).
59. Schilling, J. D., Mulvey, M. A., Vincent, C. D., Lorenz, R. G., & Hultgren, S. J. Bacterial invasion augments epithelial cytokine responses to Escherichia coli. through a lipopolysaccharide-dependent mechanism. Journal of immunology (Baltimore, Md: 1950). 166, 1148-1155 (2001).
60. Schwartz, D. J., Chen, S. L., Hultgren, S. J., & Seed, P. C. Population Dynamics and Niche Distribution of Uropathogenic Escherichia coli. during Acute and Chronic Urinary Tract Infection. Infect. Immun. 79, 4250-4259, doi:10.1128/iai.05339-11 (2011).
61. Chan, C. Y., St John, A. L., & Abraham, S. N. Mast Cell Interleukin-10 Drives Localized Tolerance in Chronic Bladder Infection. Immunity. 38, 349-359, doi:10.1016/j.immuni.2012.10.019 (2013).
62. Justice, S. S., Lauer, S. R., Hultgren, S. J., & Hunstad, D. A. Maturation of intracellular Escherichia coli. communities requires SurA. Infect. Immun. 74, 4793-4800, doi:10.1128/iai.00355-06 (2006).
63. Justice, S. S., Hunstad, D. A., Seed, P. C., & Hultgren, S. J. Filamentation by Escherichia coli. subverts innate defenses during urinary tract infection. Proceedings of the National Academy of Sciences of the United States of America. 103, 19884-19889, doi:10.1073/ pnas.0606329104 (2006).
64. Justice, S. S. et al. Differentiation and developmental pathways of uropathogenic Escherichia coli. in urinary tract pathogenesis. Proceedings of the National Academy of Sciences of the United States of America. 101, 1333-1338, doi:10.1073/pnas.0308125100 (2004).
65. Guiton, P. S., Hannan, T. J., Ford, B., Caparon, M. G., & Hultgren, S. J. Enterococcus faecalis. Overcomes Foreign Body-Mediated Inflammation To Establish Urinary Tract Infections. Infect. Immun. 81, 329-339, doi:10.1128/iai.00856-12 (2013).
66. Thumbikat, P., Waltenbaugh, C., Schaeffer, A. J., & Klumpp, D. J. Antigen-specific responses accelerate bacterial clearance in the bladder. Journal of Immunology. 176, 3080-3086, doi: 10.4049/jimmunol.176.5.3080 (2006).
67. Rosen, D. A., Hung, C.-S., Kline, K. A., & Hultgren, S. J. Streptozocin-induced diabetic mouse model of urinary tract infection. Infect. Immun. 76, 4290-4298, doi:10.1128/iai.00255-08 (2008).
68. Daneshgari, F., Leiter, E. H., Liu, G., & Reeder, J. Animal Models of Diabetic Uropathy. Journal of Urology. 182, S8-S13, doi:10.1016/ j.juro.2009.07.084 (2009).
69. Guiton, P. S. et al. Combinatorial Small-Molecule Therapy Prevents Uropathogenic Escherichia coli. Catheter-Associated Urinary Tract Infections in Mice. Antimicrobial Agents and Chemotherapy. 56, 4738-4745, doi:10.1128/aac.00447-12 (2012).
70. Totsika, M. et al. A Fim H Inhibitor Prevents Acute Bladder Infection and Treats Chronic Cystitis Caused by Multidrug-Resistant Uropathogenic Escherichia coli. ST 131. Journal of Infectious Diseases. 208, 921-928, doi:10.1093/infdis/jit245 (2013).